跳至主要内容
临床试验/NL-OMON50448
NL-OMON50448招募中不适用

on invasive prenatal testing (NIPT) of fetal genetic disorders in maternal blood - NIPT genetic disorders

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Pregnant women and their partners (18+) of which:
  • Group 1: the woman is pregnant after PGD for a chromosomal anomaly or monogenic
  • Group 2: the fetus is at risk for a chromosomal anomaly because of an adverse
  • result of regular NIPT testing (Dutch TRIDENT-1 or -2 study) for aneuploidy
  • with or without additional findings.
  • Group 3: the foetus is at high risk of having a de novo disorder on the basis
  • of ultrasonography findings and couple will undergo PND
  • Group 4: the fetus is at high risk of having inherited a dominant or recessive
  • disorder of his/her affected parent(s) and couple ask for conventional PND
  • - the pregnant woman and partner are 18 years or older
  • - the pregnant woman has sufficient understanding of Dutch language and is
  • able to give informed consent.

排除标准

  • - in the opinion of the treating physician psychological distress is so severe
  • that asking for participation is not safe.
  • - the pregnant woman is treated for a malignancy
  • - patients in group 1 (testing performed with only PCR or OnePGT for monogenic
  • disorders), group 3 and 4 will be excluded from this study if they do not opt
  • for NIPT (with/without additional findings) or PND (with at least a QF PCR of
  • chromosomes 13, 18, 21)

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

on invasive prenatal testing (NIPT) of fetal genetic... | 临床试验